Fast Locator 2012-2013: DPT Laboratories - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Fast Locator 2012-2013: DPT Laboratories

DPT is a contract development and manufacturing organization (CDMO) specializing in sterile and non-sterile semi-solid and liquid dosage forms. DPT provides fully integrated development, manufacturing and packaging solutions for biopharmaceutical and pharmaceutical products. DPT is the source for semi-solid and liquids — from concept to commercialization and beyond.

Drug development services range from pre-formulation, formulation and biopharmaceutical development, analytical development and validation, through process development.

Production capabilities include five cGMP facilities, clinical trial materials, full scale commercial production, controlled substance registration Class II – IV, and complete supply chain management.

Packaging services encompass engineering and procurement resources necessary for conventional and specialized packaging.



blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here